SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Scherer Steven E.)
 

Sökning: WFRF:(Scherer Steven E.) > (2020-2022) > A combined proteomi...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00023714naa a2201129 4500
001oai:DiVA.org:umu-186313
003SwePub
008210722s2021 | |||||||||||000 ||eng|
009oai:DiVA.org:uu-441372
009oai:prod.swepub.kib.ki.se:146192931
024a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-1863132 URI
024a https://doi.org/10.1158/1055-9965.EPI-20-11762 DOI
024a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4413722 URI
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:1461929312 URI
040 a (SwePub)umud (SwePub)uud (SwePub)ki
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Nounu, Aayahu Medical Research Council (MRC) Integrative Epidemiology Unit, Bristol Medical School, University of Bristol, Bristol, United Kingdom; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom,Univ Bristol, Bristol Med Sch, Med Res Council MRC Integrat Epidemiol Unit, Bristol, Avon, England.;Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England.4 aut
2451 0a A combined proteomics and mendelian randomization approach to investigate the effects of aspirin-targeted proteins on colorectal cancer
264 1b Elsevier,c 2021
338 a electronic2 rdacarrier
520 a Background: Evidence for aspirin’s chemopreventative properties on colorectal cancer (CRC) is substantial, but its mechanism of action is not well-understood. We combined a proteomic approach with Mendelian randomization (MR) to identify possible new aspirin targets that decrease CRC risk.Methods: Human colorectal adenoma cells (RG/C2) were treated with aspirin (24 hours) and a stable isotope labeling with amino acids in cell culture (SILAC) based proteomics approach identified altered protein expression. Protein quantitative trait loci (pQTLs) from INTERVAL (N ¼ 3,301) and expression QTLs (eQTLs) from the eQTLGen Consortium (N ¼ 31,684) were used as genetic proxies for protein and mRNA expression levels. Two-sample MR of mRNA/protein expression on CRC risk was performed using eQTL/pQTL data combined with CRC genetic summary data from the Colon Cancer Family Registry (CCFR), Colorectal Transdisciplinary (CORECT), Genetics and Epidemiology of Colorectal Cancer (GECCO) consortia and UK Biobank (55,168 cases and 65,160 controls).Results: Altered expression was detected for 125/5886 proteins. Of these, aspirin decreased MCM6, RRM2, and ARFIP2 expression, and MR analysis showed that a standard deviation increase in mRNA/protein expression was associated with increased CRC risk (OR: 1.08, 95% CI, 1.03–1.13; OR: 3.33, 95% CI, 2.46–4.50; and OR: 1.15, 95% CI, 1.02–1.29, respectively).Conclusions: MCM6 and RRM2 are involved in DNA repair whereby reduced expression may lead to increased DNA aberrations and ultimately cancer cell death, whereas ARFIP2 is involved in actin cytoskeletal regulation, indicating a possible role in aspirin’s reduction of metastasis.Impact: Our approach has shown how laboratory experiments and population-based approaches can combine to identify aspirin-targeted proteins possibly affecting CRC risk.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng
650 7a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Medicinsk genetik0 (SwePub)301072 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Medical Genetics0 (SwePub)301072 hsv//eng
700a Greenhough, Alexanderu School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom; Centre for Research in Biosciences, Faculty of Health and Applied Sciences, University of the West of England, Bristol, United Kingdom,Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England.;Univ West England, Fac Hlth & Appl Sci, Ctr Res Biosci, Bristol, Avon, England.4 aut
700a Heesom, Kate J.u Proteomics Facility, Faculty of Life Sciences, University of Bristol, Bristol, United Kingdom,Univ Bristol, Fac Life Sci, Prote Facil, Bristol, Avon, England.4 aut
700a Richmond, Rebecca C.u Medical Research Council (MRC) Integrative Epidemiology Unit, Bristol Medical School, University of Bristol, Bristol, United Kingdom,Univ Bristol, Bristol Med Sch, Med Res Council MRC Integrat Epidemiol Unit, Bristol, Avon, England.4 aut
700a Zheng, Jieu Medical Research Council (MRC) Integrative Epidemiology Unit, Bristol Medical School, University of Bristol, Bristol, United Kingdom,Univ Bristol, Bristol Med Sch, Med Res Council MRC Integrat Epidemiol Unit, Bristol, Avon, England.4 aut
700a Weinstein, Stephanie J.u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, MD, Bethesda, United States,NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.4 aut
700a Albanes, Demetriusu Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, MD, Bethesda, United States,NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.4 aut
700a Baron, John A.u Department of Medicine, University of North Carolina School of Medicine, NC, Chapel Hill, United States,Univ N Carolina, Dept Med, Sch Med, Chapel Hill, NC USA.4 aut
700a Hopper, John L.u Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, VIC, Melbourne, Australia; Depart-ment of Epidemiology, School of Public Health and Institute of Health and Environment, Seoul National University, Seoul, South Korea,Univ Melbourne, Ctr Epidemiol & Biostat, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia.;Seoul Natl Univ, Sch Publ Hlth, Dept Epidemiol, Seoul, South Korea.;Seoul Natl Univ, Inst Hlth & Environm, Seoul, South Korea.,Univ Virginia, Dept Family Med, Charlottesville, VA USA.4 aut
700a Figueiredo, Jane C.u Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, CA, Los Angeles, United States; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, CA, Los Angeles, United States,Cedars Sinai Med Ctr, Dept Med, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA.;Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA USA.4 aut
700a Newcomb, Polly A.u Public Health Sciences Division, Fred Hutchinson Cancer Research Center, WA, Seattle, United States; School of Public Health, University of Washington, WA, Seattle, United States,Fred Hutchinson Canc Res Ctr, Publ Hlth Sci Div, 1124 Columbia St, Seattle, WA 98104 USA.;Univ Washington, Sch Publ Hlth, Seattle, WA 98195 USA.4 aut
700a Lindor, Noralane M.u Department of Health Science Research, Mayo Clinic, AZ, Scottsdale, United States,Mayo Clin, Dept Hlth Sci Res, Scottsdale, AZ USA.4 aut
700a Casey, Grahamu Center for Public Health Genomics, University of Virginia, VA, Charlottesville, United States,Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA.4 aut
700a Platz, Elizabeth A.u Department of Epidemiology, Johns Hopkins Bloom-berg School of Public Health, MD, Baltimore, United States,Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.4 aut
700a Le Marchand, Locu University of Hawaii Cancer Center, HI, Honolulu, United States,Univ Hawaii Canc Ctr, Honolulu, HI USA.4 aut
700a Ulrich, Cornelia M.u Huntsman Cancer Institute, Department of Population Health Sciences, University of Utah, UT, Salt Lake City, United States,Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA.;Univ Utah, Dept Populat Hlth Sci, Salt Lake City, UT USA.4 aut
700a Li, Christopher I.u Public Health Sciences Division, Fred Hutchinson Cancer Research Center, WA, Seattle, United States,Fred Hutchinson Canc Res Ctr, Publ Hlth Sci Div, 1124 Columbia St, Seattle, WA 98104 USA.4 aut
700a van Duijnhoven, Franzel J.B.u Division of Human Nutrition and Health, Wageningen University and Research, Wageningen, Netherlands,Wageningen Univ & Res, Div Human Nutr & Hlth, Wageningen, Netherlands.4 aut
700a Gsur, Andreau Institute of Cancer Research, Department of Medicine I, Medical University Vienna, Vienna, Austria,Med Univ Vienna, Inst Canc Res, Dept Med 1, Vienna, Austria.4 aut
700a Campbell, Peter T.u Behavioral and Epidemiology Research Group, American Cancer Society, GA, Atlanta, United States,Amer Canc Soc, Behav & Epidemiol Res Grp, Atlanta, GA 30329 USA.4 aut
700a Moreno, Víctoru Oncology Data Analytics Program, Catalan Institute of Oncology-IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain; CIBER Epidemiología y Salud Publica (CIBERESP), Madrid, Spain; Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Barcelona, Spain; ONCOBEL Program, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain,Catalan Inst Oncol IDIBELL, Oncol Data Analyt Program, Barcelona, Spain.;CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain.;Univ Barcelona, Fac Med, Dept Clin Sci, Barcelona, Spain.;Bellvitge Biomed Res Inst IDIBELL, ONCOBEL Program, Barcelona, Spain.4 aut
700a Vodicka, Pavelu Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czech Republic; Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Prague, Czech Republic; Faculty of Medicine and Biomedical Center in Pilsen, Charles University, Pilsen, Czech Republic,Czech Acad Sci, Dept Mol Biol Canc, Inst Expt Med, Prague, Czech Republic.;Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Prague, Czech Republic.;Charles Univ Prague, Fac Med, Plzen, Czech Republic.;Charles Univ Prague, Biomed Ctr Pilsen, Plzen, Czech Republic.4 aut
700a Vodickova, Ludmilau Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czech Republic; Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Prague, Czech Republic; Faculty of Medicine and Biomedical Center in Pilsen, Charles University, Pilsen, Czech Republic,Czech Acad Sci, Dept Mol Biol Canc, Inst Expt Med, Prague, Czech Republic.;Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Prague, Czech Republic.;Charles Univ Prague, Fac Med, Plzen, Czech Republic.;Charles Univ Prague, Biomed Ctr Pilsen, Plzen, Czech Republic.4 aut
700a Brenner, Hermannu Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany; Division of Preventive Oncology, German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT), Heidelberg, Germany; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany,German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany.;German Canc Res Ctr, Div Prevent Oncol, Heidelberg, Germany.;Natl Ctr Tumor Dis NCT, Heidelberg, Germany.;German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany.4 aut
700a Chang-Claude, Jennyu Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Uni-versity Medical Centre Hamburg-Eppendorf, University Cancer Centre Hamburg (UCCH), Hamburg, Germany,German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany.;Univ Canc Ctr Hamburg UCCH, Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany.4 aut
700a Hoffmeister, Michaelu Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany,German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany.4 aut
700a Sakoda, Lori C.u Public Health Sciences Division, Fred Hutchinson Cancer Research Center, WA, Seattle, United States; Division of Research, Kaiser Permanente Northern California, CA, Oakland, United States,Fred Hutchinson Canc Res Ctr, Publ Hlth Sci Div, 1124 Columbia St, Seattle, WA 98104 USA.;Kaiser Permanente Northern Calif, Div Res, Oakland, CA USA.4 aut
700a Slattery, Martha L.u Department of Internal Medicine, University of Utah, UT, Salt Lake City, United States,Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA.4 aut
700a Schoen, Robert E.u Department of Medicine and Epidemiology, University of Pittsburgh Medical Center, PA, Pittsburgh, United States,Univ Pittsburgh, Med Ctr, Dept Med & Epidemiol, Pittsburgh, PA USA.4 aut
700a Gunter, Marc J.u Nutrition and Metabolism Section, International Agency for Research on Cancer, World Health Organization, Lyon, France,World Hlth Org, Nutr & Metab Sect, Int Agcy Res Canc, Lyon, France.4 aut
700a Castellví-Bel, Sergiu Gastroenterology Department, Hospital Clínic, Institut d’Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBEREHD), University of Barcelona, Barcelona, Spain,Univ Barcelona, Hosp Clin, Gastroenterol Dept,Ctr Invest Biomed Red Enfermed, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain.4 aut
700a Kim, Hyeong Roku Depart-ment of Surgery, Chonnam National University Hwasun Hospital and Medical School, Hwasun, South Korea,Chonnam Natl Univ, Dept Surg, Hwasun Hosp & Med Sch, Hwasun, South Korea.4 aut
700a Kweon, Sun-Seogu Department of Preventive Medicine, Chonnam National University Medical School, Gwangju, South Korea; Jeonnam Regional Cancer Center, Chonnam National University Hwasun Hospital, Hwasun, South Korea,Chonnam Natl Univ, Dept Prevent Med, Med Sch, Gwangju, South Korea.;Chonnam Natl Univ, Jeonnam Reg Canc Ctr, Hwasun Hosp, Hwasun, South Korea.4 aut
700a Chan, Andrew T.u Divi-sion of Gastroenterology, Massachusetts General Hospital, Harvard Medical School, MA, Boston, United States; Channing Division of Network Medicine, Brigham and Women’s Hospital, Harvard Medical School, MA, Boston, United States; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Harvard Medical School, MA, Boston, United States; Broad Institute of Harvard and MIT, MA, Cambridge, United States; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, MA, Boston, United States; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Harvard University, MA, Boston, United States,Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA.;Harvard Med Sch, Boston, MA 02115 USA.;Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.;Massachusetts Gen Hosp, Clin & Translat Epidemiol Unit, Boston, MA 02114 USA.;Broad Inst Harvard & Mit, Cambridge, MA USA.;Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.;Harvard Univ, Dept Immunol & Infect Dis, Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.4 aut
700a Li, Liu Department of Family Medicine, University of Virginia, VA, Charlottesville, United States,Univ Bristol, Bristol Med Sch, Med Res Council MRC Integrat Epidemiol Unit, Bristol, Avon, England.4 aut
700a Zheng, Weiu Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt Epidemiology Center, Vanderbilt University School of Medicine, TN, Nashville, United States,Vanderbilt Univ, Sch Med, Vanderbilt Epidemiol Ctr, Div Epidemiol,Dept Med,Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA.4 aut
700a Bishop, D. Timothyu Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, United Kingdom,Univ Leeds, Leeds Inst Canc & Pathol, Leeds, W Yorkshire, England.4 aut
700a Buchanan, Daniel D.u Colorectal Oncogenomics Group, Department of Clinical Pathology, University of Melbourne, VIC, Parkville, Australia; University of Melbourne Centre for Cancer Research, Victorian Comprehensive Cancer Centre, VIC, Parkville, Australia; Genetic Medicine and Family Cancer Clinic, Royal Melbourne Hospital, VIC, Parkville, Australia,Univ Melbourne, Dept Clin Pathol, Colorectal Oncogen Grp, Parkville, Vic, Australia.;Univ Melbourne, Ctr Canc Res, Victorian Comprehens Canc Ctr, Parkville, Vic, Australia.;Royal Melbourne Hosp, Genet Med & Family Canc Clin, Parkville, Vic, Australia.4 aut
700a Giles, Graham G.u Cancer Epidemiology Division, Cancer Council Victoria, VIC, Melbourne, Australia; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, VIC, Clayton, Australia,Canc Council Victoria, Canc Epidemiol Div, Melbourne, Vic, Australia.;Monash Univ, Sch Clin Sci, Monash Hlth, Precis Med, Clayton, Vic, Australia.4 aut
700a Gruber, Stephen B.u Department of Preventive Medicine, USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, CA, Los Angeles, United States,Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA USA.;Univ Southern Calif, Keck Sch Med, USC Norris Comprehens Canc Ctr, Los Angeles, CA 90007 USA.4 aut
700a Rennert, Gadu Depart-ment of Community Medicine and Epidemiology, Lady Davis Carmel Medical Center, Haifa, Israel; Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel; Clalit National Cancer Control Center, Haifa, Israel,Lady Davis Carmel Med Ctr, Dept Community Med & Epidemiol, Haifa, Israel.;Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Haifa, Israel.;Clalit Natl Canc Control Ctr, Haifa, Israel.4 aut
700a Stadler, Zsofia K.u Department of Medicine, Memorial Sloan Kettering Cancer Center, NY, New York, United States,Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.4 aut
700a Harrison, Tabitha A.u Public Health Sciences Division, Fred Hutchinson Cancer Research Center, WA, Seattle, United States,Fred Hutchinson Canc Res Ctr, Publ Hlth Sci Div, 1124 Columbia St, Seattle, WA 98104 USA.4 aut
700a Lin, Yiu Public Health Sciences Division, Fred Hutchinson Cancer Research Center, WA, Seattle, United States,Fred Hutchinson Canc Res Ctr, Publ Hlth Sci Div, 1124 Columbia St, Seattle, WA 98104 USA.4 aut
700a Keku, Temitope O.u Center for Gastrointestinal Biology and Disease, University of North Carolina, NC, Chapel Hill, United States,Univ N Carolina, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC USA.4 aut
700a Woods, Michael O.u Discipline of Genetics, Memorial University of Newfoundland, St. John’s, Canada,Mem Univ Newfoundland, Discipline Genet, St John, NF, Canada.4 aut
700a Schafmayer, Clemensu Depart-ment of General Surgery, University Hospital Rostock, Rostock, Germany,Univ Hosp Rostock, Dept Gen Surg, Rostock, Germany.4 aut
700a van Guelpen, Bethanyu Umeå universitet,Wallenberg centrum för molekylär medicin vid Umeå universitet (WCMM),Onkologi,Umeå Univ, Dept Radiat Sci, Oncol Unit, Umeå, Sweden.;Umeå Univ, Wallenberg Ctr Mol Med, Umeå, Sweden.4 aut0 (Swepub:umu)beyvan99
700a Gallinger, Stevenu Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, ON, Toronto, Canada,Univ Toronto, Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada.4 aut
700a Hampel, Heatheru Division of Human Genetics, Department of Internal Medicine, Ohio State University Comprehensive Cancer Center, OH, Columbus, United States,Ohio State Univ, Dept Internal Med, Div Human Genet, Comprehens Canc Ctr, Columbus, OH 43210 USA.,Univ Southern Calif, Preventat Med, Los Angeles, CA 90007 USA.4 aut
700a Berndt, Sonja I.u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, MD, Bethesda, United States,NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.4 aut
700a Pharoah, Paul D.P.u Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom,Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England.4 aut
700a Lindblom, Annikau Karolinska Institutet4 aut
700a Wolk, Alicjau Karolinska Institutet,Uppsala universitet,Ortopedi,Karolinska Inst, Inst Environm Med, Stockholm, Sweden.;Uppsala Univ, Dept Surg Sci, Uppsala, Sweden.4 aut0 (Swepub:uu)alwol516
700a Wu, Anna H.u University of Southern California, Preventative Medicine, CA, Los Angeles, United States4 aut
700a White, Emilyu Public Health Sciences Division, Fred Hutchinson Cancer Research Center, WA, Seattle, United States; Department of Epidemiology, University of Washington School of Public Health, WA, Seattle, United States,Fred Hutchinson Canc Res Ctr, Publ Hlth Sci Div, 1124 Columbia St, Seattle, WA 98104 USA.;Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA.4 aut
700a Peters, Ulrikeu Public Health Sciences Division, Fred Hutchinson Cancer Research Center, WA, Seattle, United States; Department of Epidemiology, University of Washington School of Public Health, WA, Seattle, United States,Fred Hutchinson Canc Res Ctr, Publ Hlth Sci Div, 1124 Columbia St, Seattle, WA 98104 USA.;Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA.4 aut
700a Drew, David A.u Massachusetts General Hospital, Harvard Medical School, Clinical and Translational Epidemiology Unit, MA, Boston, United States,Massachusetts Gen Hosp, Boston, MA 02114 USA.;Harvard Med Sch, Clin & Translat Epidemiol Unit, Boston, MA 02115 USA.4 aut
700a Scherer, Dominiqueu Institute of Medical Biometry and Informatics, University of Heidelberg, Heidelberg, Germany,Heidelberg Univ, Inst Med Biometry & Informat, Heidelberg, Germany.4 aut
700a Bermejo, Justo Lorenzou Institute of Medical Biometry and Informatics, University of Heidelberg, Heidelberg, Germany,Heidelberg Univ, Inst Med Biometry & Informat, Heidelberg, Germany.4 aut
700a Williams, Ann C.u School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom,Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England.4 aut
700a Relton, Caroline L.u Medical Research Council (MRC) Integrative Epidemiology Unit, Bristol Medical School, University of Bristol, Bristol, United Kingdom4 aut
710a Medical Research Council (MRC) Integrative Epidemiology Unit, Bristol Medical School, University of Bristol, Bristol, United Kingdom; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdomb Univ Bristol, Bristol Med Sch, Med Res Council MRC Integrat Epidemiol Unit, Bristol, Avon, England.;Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England.4 org
773t Cancer Epidemiology, Biomarkers and Preventiond : Elsevierg 30:3, s. 564-575q 30:3<564-575x 1055-9965x 1538-7755
856u https://doi.org/10.1158/1055-9965.EPI-20-1176y Fulltext
856u https://umu.diva-portal.org/smash/get/diva2:1581529/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-186313
8564 8u https://doi.org/10.1158/1055-9965.EPI-20-1176
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-441372
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:146192931

Hitta via bibliotek

Till lärosätets databas

Hitta mer i SwePub

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy